Two of the key IP questions for small companies are: How can I base my business strategy on IP when I know that there is always a risk that I will...
It’s wrong to think that a patent can automatically stop your competitor from entering a market, or making a competitor product. Just wrong. Patents are hurdles, not walls. Each of them...
Just don’t read any further unless you’re deep in to pharmaceuticals. For those who are still reading, every now and then there’s a case or two that we just can’t...
Apparently not! According to a recent report from the International Intellectual Property Association US copyright industries are in fact booming compared to US GDP. Ars Technica picked up the issue and...
The Hatch Waxman legislation is intended to strike a balance between encouraging innovation and affordable access to medication. In short, the Act offers a patent term restoration to compensate the innovator...
Well known Indian IP advocate – Feroz Ali is out with his second book on patents. The last time around, Feroz wrote a treatise on the Indian patent law with a...
In preparing for potential intellectual property litigation, it’s quite common to speak to a number of experts to identify the best one possible for the case.So, in light of the confidential...
For those of you who are unfamiliar with US litigation practice, Rule 11 (of the Federal Rules of Civil Procedure) requires attorneys or parties to make reasonable enquiries before filing a...
I posted a couple of notes (here and here) yesterday at SpicyIP about Novartis’ alpha crystalline Glivec (imatinib) patent which has recently come to light. This application was filed back in...
I recently listened to TIME’s podcast marking the 25th anniversary of ‘The Play‘. For those like me who don’t follow the game, ‘The Play‘ refers to the historic dying seconds of...
You must be logged in to post a comment.